Financings Of The Fortnight Sees New Biotech Funding All Over The Globe, And Without Much VC Participation

 
• By Alex Lash, John Davis, and Lisa LaMotta

Plus news on recent financial activity by Merrimack, Promethera, ADC Therapeutics and Enterome Bioscience.

More from United States

More from North America